BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Prognosis
34 results:

  • 1. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
    Liu B; Liu XY; Wang GP; Chen YX
    Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic and predictive biomarkers in paediatric solid tumours.
    Glembocki AI; Somers GR
    Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.
    Mochizuki T; Ikegami M; Akiyama T
    Cancer Sci; 2024 Feb; 115(2):575-588. PubMed ID: 38115234
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diverse cell death patterns-related signature for predicting prognosis and drug sensitivity of osteosarcoma patients.
    Shi Y; Wu S; Zhang X; Cao Y; Zhang L
    J Gene Med; 2024 Jan; 26(1):e3613. PubMed ID: 37861176
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. 5hmC Immunohistochemistry: A Predictor of
    Hysek M; Hellgren SL; Condello V; Xu Y; Larsson C; Zedenius J; Juhlin CC
    J Histochem Cytochem; 2023 Aug; 71(8):451-458. PubMed ID: 37486076
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Distinct IDH1/2-associated Methylation Profile and Enrichment of
    Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
    Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Digital droplet PCR tert promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre-operative identification of high-risk cases.
    Hysek M; Hellgren LS; Stenman A; Darai-Ramqvist E; Ljung E; Schliemann I; Condello V; Larsson C; Zedenius J; Jatta K; Juhlin CC
    Diagn Cytopathol; 2023 Jun; 51(6):331-340. PubMed ID: 36870048
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pan-Cancer analysis of tert and Validation in Osteosarcoma Cell Lines.
    Xie L; Yin W; Tang F; He M
    Biochem Biophys Res Commun; 2023 Jan; 639():106-116. PubMed ID: 36476950
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A genetic model for central chondrosarcoma evolution correlates with patient outcome.
    Cross W; Lyskjær I; Lesluyes T; Hargreaves S; Strobl AC; Davies C; Waise S; Hames-Fathi S; Oukrif D; Ye H; Amary F; Tirabosco R; Gerrand C; Baker T; Barnes D; Steele C; Alexandrov L; Bond G; ; Cool P; Pillay N; Van Loo P; Flanagan AM
    Genome Med; 2022 Aug; 14(1):99. PubMed ID: 36042521
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
    Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
    Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell line.
    Shi C; Gu Z; Xu S; Ju H; Wu Y; Han Y; Li J; Li C; Wu J; Wang L; Li J; Zhou G; Ye W; Ren G; Zhang Z; Zhou R
    Cancer Commun (Lond); 2022 Jul; 42(7):627-647. PubMed ID: 35666052
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Apoptosis-related genes-based prognostic signature for osteosarcoma.
    Yang F; Zhang Y
    Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. High prevalence of tert aberrations in myxoid liposarcoma: tert reactivation may play a crucial role in tumorigenesis.
    Kunieda J; Yamashita K; Togashi Y; Baba S; Sakata S; Inamura K; Ae K; Matsumoto S; Machinami R; Kitagawa M; Takeuchi K
    Cancer Sci; 2022 Mar; 113(3):1078-1089. PubMed ID: 34971481
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Oligosarcomas, IDH-mutant are distinct and aggressive.
    Suwala AK; Felix M; Friedel D; Stichel D; Schrimpf D; Hinz F; Hewer E; Schweizer L; Dohmen H; Pohl U; Staszewski O; Korshunov A; Stein M; Wongsurawat T; Cheunsuacchon P; Sathornsumetee S; Koelsche C; Turner C; Le Rhun E; Mühlebner A; Schucht P; Özduman K; Ono T; Shimizu H; Prinz M; Acker T; Herold-Mende C; Kessler T; Wick W; Capper D; Wesseling P; Sahm F; von Deimling A; Hartmann C; Reuss DE
    Acta Neuropathol; 2022 Feb; 143(2):263-281. PubMed ID: 34967922
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
    Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
    Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Inhibition of Ras and STAT3 activity of 4-(
    Kirtishanti A; Siswodihardjo S; Sudiana IK; Suprabawati DGA; Dinaryanti A
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):363-371. PubMed ID: 34214366
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
    Ak M; Kahraman A; Arnold FM; Turko P; Levesque MP; Zoche M; Ramelyte E; Dummer R
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202213
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
    Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metastatic-prone telomerase reverse transcriptase (tert) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.
    Stenman A; Koman A; Ihre-Lundgren C; Juhlin CC
    Medicine (Baltimore); 2021 Jan; 100(2):e24237. PubMed ID: 33466206
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.